Icon

DOXIL (LIPOSOMAL) (nda050718)- (20MG/10ML (2MG/ML),50MG/25ML (2MG/ML))

DOXORUBICIN HYDROCHLORIDE BAXTER HLTHCARE CORP
20MG/10ML (2MG/ML),50MG/25ML (2MG/ML)
No No
2009-Oct-20 Expired
2014-May-17 None
None No
DOXIL is an anthracycline topoisomerase inhibitor indicated for:  Ovarian cancer: After failure of platinum-based chemotherapy.  AIDS-related Kaposi’s Sarcoma: After failure of prior systemic. chemotherapy or intolerance to such therapy.  Multiple Myeloma: In combination with bortezomib in patients who have not previously received bortezomib and have received at least one prior therapy.
5 0 4
Total Other Developers None
Drugs with Suitability No
20MG/10ML (2MG/ML) ** ** - - -
50MG/25ML (2MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 4
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** *** ***** *** ************** ********** ******* *********** *****-****** *******, *****, ******* ******, ***** (***) ***
****** ***** ****** *** ******** ********* ******* *********** ***** ******* ******* ****** (***), *****, *******, ****** (***) ***
****** ** ****** ***** ****** ******* *********** ****** ********, ******, **********, ********* *** ***, ***** (***) ***
****** ***** ************ ***** ************ ******* *********** **** **. **, ******* ******* ******** ****, ******* - ***** *. *. **. **, ******, *** : ******, *********, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.